ArticleCancer medicine2024

Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma.

Baoluhe Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.